Test for ovulation

Reading File
Finding Sources
Finding Sources
Searching Images

ovulation test LH surge urine test

This pathophysiology diagram illustrates peroxisomal regulation during folliculogenesis and ovulation. The top sequence depicts morphological follicle progression from a primary follicle through a secondary follicle to a tertiary follicle (showing antrum formation), culminating in a preovulatory follicle and LH surge-triggered ovulation. The diagram outlines two primary peroxisomal pathways: 1) ROS balance, where upregulation of Catalase, Pex14, and plasmalogens promotes oocyte maturation while inhibiting meiotic arrest and apoptosis; and 2) β-oxidation, where upregulation of ABCD3, MFP2, and GNPAT increases ATP generation and nutritional supply while decreasing lipid toxicity to support oocyte maturation. During the ovulation phase, the schematic shows a shift characterized by the downregulation of Catalase and SODs, leading to an increase in Reactive Oxygen Species (ROS) levels. Key educational concepts include the role of peroxisomes in metabolic support, antioxidant defense, and the transition of oxidative states required for successful oocyte release.

This pathophysiology diagram illustrates peroxisomal regulation during folliculogenesis and ovulation. The top sequence depicts morphological follicle progression from a primary follicle through a secondary follicle to a tertiary follicle (showing antrum formation), culminating in a preovulatory follicle and LH surge-triggered ovulation. The diagram outlines two primary peroxisomal pathways: 1) ROS balance, where upregulation of Catalase, Pex14, and plasmalogens promotes oocyte maturation while inhibiting meiotic arrest and apoptosis; and 2) β-oxidation, where upregulation of ABCD3, MFP2, and GNPAT increases ATP generation and nutritional supply while decreasing lipid toxicity to support oocyte maturation. During the ovulation phase, the schematic shows a shift characterized by the downregulation of Catalase and SODs, leading to an increase in Reactive Oxygen Species (ROS) levels. Key educational concepts include the role of peroxisomes in metabolic support, antioxidant defense, and the transition of oxidative states required for successful oocyte release.

A multi-panel pathophysiology diagram illustrating the synchronous physiological changes during a standard 28-day human menstrual cycle. The top panel graphs gonadotropin levels, showing a sharp surge in Luteinizing Hormone (LH) and a moderate rise in Follicle-Stimulating Hormone (FSH) at day 14, correlating with the follicular phase, ovulation, and luteal phase stages. The corresponding follicular development shows the maturation of a primary follicle into a Graafian follicle, ovulation, and the formation of the corpus luteum and corpus albicans. The middle panel tracks plasma sex hormone levels, highlighting the mid-cycle peak of Estradiol (E2) and the post-ovulatory rise of Progesterone (P4). The bottom panel depicts endometrial morphology, transitioning from the menstrual phase to the proliferative and secretory phases. A green-shaded layer highlights the glycocalyx development, which thickens and becomes most prominent during the secretory phase under the influence of P4, before thinning during menstruation. The diagram demonstrates the hormonal regulation of the ovary and uterine lining for medical educational purposes.

A multi-panel pathophysiology diagram illustrating the synchronous physiological changes during a standard 28-day human menstrual cycle. The top panel graphs gonadotropin levels, showing a sharp surge in Luteinizing Hormone (LH) and a moderate rise in Follicle-Stimulating Hormone (FSH) at day 14, correlating with the follicular phase, ovulation, and luteal phase stages. The corresponding follicular development shows the maturation of a primary follicle into a Graafian follicle, ovulation, and the formation of the corpus luteum and corpus albicans. The middle panel tracks plasma sex hormone levels, highlighting the mid-cycle peak of Estradiol (E2) and the post-ovulatory rise of Progesterone (P4). The bottom panel depicts endometrial morphology, transitioning from the menstrual phase to the proliferative and secretory phases. A green-shaded layer highlights the glycocalyx development, which thickens and becomes most prominent during the secretory phase under the influence of P4, before thinning during menstruation. The diagram demonstrates the hormonal regulation of the ovary and uterine lining for medical educational purposes.

This pathophysiology diagram illustrates the sequential stages of ovarian follicular development and the regulatory factors influencing the ovulation rate, using a murine model for context. The process initiates with primordial follicles, which undergo 'Activation' to become preantral follicles. These then mature into antral follicles, eventually culminating in ovulation. The Hypothalamic-Pituitary-Gonadal (HPG) axis is shown influencing the cycle through GnRH, which regulates LH and FSH, along with Progesterone (P4) involvement. Key regulatory pathways highlighted include 'Follicular survival,' which leads toward ovulation, and an opposing pathway for 'Follicular atresia.' The diagram maps specific molecular markers to the Diestrus and Estrus stages of the cycle. During Diestrus, follicular activation and survival are associated with Foxl2, Kit, Smad1, Lhcgr, Cxcr4, and Nos2. During Estrus, these processes involve Esr1, Fgf2, and Igfbp2. The educational focus is on the complex interplay between endocrine signaling and local gene expression that determines follicular fate and overall ovulation rate.

This pathophysiology diagram illustrates the sequential stages of ovarian follicular development and the regulatory factors influencing the ovulation rate, using a murine model for context. The process initiates with primordial follicles, which undergo 'Activation' to become preantral follicles. These then mature into antral follicles, eventually culminating in ovulation. The Hypothalamic-Pituitary-Gonadal (HPG) axis is shown influencing the cycle through GnRH, which regulates LH and FSH, along with Progesterone (P4) involvement. Key regulatory pathways highlighted include 'Follicular survival,' which leads toward ovulation, and an opposing pathway for 'Follicular atresia.' The diagram maps specific molecular markers to the Diestrus and Estrus stages of the cycle. During Diestrus, follicular activation and survival are associated with Foxl2, Kit, Smad1, Lhcgr, Cxcr4, and Nos2. During Estrus, these processes involve Esr1, Fgf2, and Igfbp2. The educational focus is on the complex interplay between endocrine signaling and local gene expression that determines follicular fate and overall ovulation rate.

<table>
  <tr>
    <td colspan="3"><span style="color:#00b6c4"><b>Confirmation of ovulation</b></span></td>
  </tr>
  <tr>
    <td>1</td>
    <td>In women with regular menstrual cycles, tests for confirmation of ovulation are not routinely recommended.</td>
    <td>GPP</td>
  </tr>
  <tr>
    <td>2</td>
    <td>In women with regular menstrual cycles, if confirmation of ovulation is warranted, tests such as urinary LH measurements, ultrasound monitoring or mid-luteal progesterone measurement can be used.</td>
    <td>Conditional<br>⊕◯◯◯</td>
  </tr>
</table>

<table> <tr> <td colspan="3"><span style="color:#00b6c4"><b>Confirmation of ovulation</b></span></td> </tr> <tr> <td>1</td> <td>In women with regular menstrual cycles, tests for confirmation of ovulation are not routinely recommended.</td> <td>GPP</td> </tr> <tr> <td>2</td> <td>In women with regular menstrual cycles, if confirmation of ovulation is warranted, tests such as urinary LH measurements, ultrasound monitoring or mid-luteal progesterone measurement can be used.</td> <td>Conditional<br>⊕◯◯◯</td> </tr> </table>

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Loading Image
Here is a thorough review of the tests used to detect or confirm ovulation, drawn from Berek & Novak's Gynecology, Tietz Textbook of Laboratory Medicine, Harrison's Principles of Internal Medicine, and Ganong's Review of Medical Physiology.

Tests for Ovulation

Why test for ovulation?

Ovulation testing serves two purposes: prediction (identify the fertile window to time intercourse or insemination) and confirmation (verify that ovulation actually occurred, usually in an infertility workup). No single test does both perfectly.

1. Urinary LH (Ovulation Predictor Kits) - Most Widely Used

LH appears in the urine approximately 2 hours after the serum LH surge peaks, and ovulation follows the surge by 24-48 hours (Berek & Novak's Gynecology, p. 2049).
How they work:
  • Home dipstick ELISA kits detect urinary LH using a threshold of 35-50 mIU/mL
  • Most are accurate, inexpensive, and convenient
  • Positive predictive value: 92% | Negative predictive value: 95%
  • Because the surge may last less than 12 hours, twice-daily testing increases detection rates
Limitations:
  • The two highest-probability conception days are the day of and day before the LH surge - so detecting the surge may already be "late" for optimal timing
  • False positives in ~7% of cycles (may reflect premature unsustained LH surges)
  • Not reliable in women with irregular cycles
  • A positive result does not guarantee ovulation will actually occur - it only predicts it
  • Measurement does not confirm ovulation or explain anovulation causes
(Tietz Textbook of Laboratory Medicine, 7th Ed., p. 2830; Berek & Novak's Gynecology, p. 2049)

2. Midluteal Serum Progesterone - Best for Confirmation

Progesterone rises immediately after ovulation as the corpus luteum forms, peaking during the midluteal phase (days 21-23 of a 28-day cycle, or 7 days after the LH surge).
Interpretation:
  • A level >3 ng/mL (10 nmol/L) confirms corpus luteum formation and is taken as evidence of ovulation
  • Tietz puts the cutoff even higher: >300 ng/dL (9.5 nmol/L) indicates ovulation has taken place
  • In practice, ovulatory levels are often considerably higher than 3 ng/mL
Important caveat:
Progesterone confirms corpus luteum formation - it does NOT confirm that the oocyte was physically released. Luteinized unruptured follicle syndrome (LUF) can give a normal progesterone rise without actual oocyte release. Also, progesterone is secreted in frequent pulses, so a single low midluteal value is not definitively diagnostic of anovulation.
(Berek & Novak's Gynecology, p. 2049; Tietz Textbook of Laboratory Medicine, p. 2824-2826)

3. Basal Body Temperature (BBT)

Progesterone is thermogenic. After ovulation, the rising progesterone level causes a temperature rise of about 0.5-1°F (0.1-0.3°C) over the follicular-phase baseline of 97-98.8°F.
How to perform:
  • Use a BBT thermometer to record oral or rectal temperature every morning before arising, eating, or drinking
  • Ovulation is assumed after 3 consecutive days of elevated temperature
  • A biphasic pattern (low follicular / high luteal) characterizes ovulatory cycles
Limitations:
  • Only retrospective - the rise begins 1-2 days after ovulation, so it cannot predict the fertile window
  • Frequent false negatives
  • Affected by smoking, irregular sleep patterns, illness
  • Not useful for timing intercourse prospectively
(Berek & Novak's Gynecology, p. 2048; Ganong's Review of Medical Physiology, p. 408; Tietz, p. 2828)

4. Transvaginal Ultrasound (US) - Gold Standard for Real-Time Monitoring

Ultrasound directly visualizes follicle growth and rupture.
Findings confirming ovulation:
  • Pre-ovulatory follicle reaches 17-19 mm (spontaneous cycles) or 19-25 mm (clomiphene-induced cycles)
  • Ovulation = sudden decrease in follicle size + appearance of free fluid in the cul-de-sac
Combined protocol: Begin LH kit testing when US-measured follicle reaches 14 mm.
Luteinized Unruptured Follicle (LUF) syndrome:
  • 10% of cycles in normally fertile women show apparent ovulation on hormonal tests but no visible follicle rupture on daily US
  • Rises to 25% in women with unexplained infertility
  • Only US can detect this - hormone tests will appear normal
Limitation: Expensive, inconvenient, requires serial visits. Reserved for patients who fail simpler methods or are undergoing ovulation induction.
(Berek & Novak's Gynecology, p. 2049)

5. Cervical Mucus Assessment

During the fertile window, cervical mucus becomes slippery, clear, and abundant ("egg-white" consistency). Volume peaks 2-3 days before ovulation. At other times, it is dry and sticky. This can be used alongside BBT (the sympto-thermal method) for natural family planning.
(Berek & Novak's Gynecology, p. 2048)

Summary Comparison Table

TestPredicts or Confirms?TimingKey ThresholdLimitation
Urinary LH kitPredicts (24-48 h before)Mid-cycle35-50 mIU/mLNo confirmation of actual ovulation; unreliable with irregular cycles
Serum progesteroneConfirms (retrospective)Day 21-23 or 7 days post-LH>3 ng/mL (>300 ng/dL)Does not confirm oocyte release; pulsatile secretion complicates interpretation
Basal body temperatureConfirms (retrospective)Rise 1-2 days after ovulation0.5-1°F riseRetrospective only; frequent false negatives
Transvaginal ultrasoundConfirms (real-time)Follicular monitoringFollicle 17-19 mm then collapseExpensive; can detect LUF
Cervical mucusPredicts (2-3 days before)Peri-ovulatoryClear, slippery mucusSubjective; affected by infections, medications

Clinical guideline note:
Confirmation of ovulation guidelines
In women with regular menstrual cycles, routine ovulation testing is not recommended. If confirmation is warranted (e.g., infertility workup), urinary LH measurement, ultrasound monitoring, or mid-luteal progesterone can be used (conditional recommendation, very low certainty evidence).
This is a shared conversation. Sign in to Orris to start your own chat.